My primary research interest focuses on pharmacotherapy for pain and substance use disorder. We pharmacologically investigate the functional profiles of both clinically used drugs and newly developed compounds in non-human primates to facilitate translational medicine. By integrating a variety of behavioral and physiological assays in primates, my research aims to elucidate and validate the therapeutic potential of novel targets. In addition, we examine the effects of novel compounds following acute and chronic administration in primates under different states. Ongoing projects investigate 1) the therapeutic potential of experimental compounds as safe, non-addictive analgesics, 2) the functional efficacy of novel compounds for ameliorating opioid-associated side effects or opioid/cocaine use disorder, and 3) spinal and supraspinal ligand-receptor systems for regulating pain and itch.
Educational Program Involvement
Integrative Physiology and Pharmacology PhD
Program Research Interest: Drug and Alcohol Abuse, Cardiovascular Physiology and Hypertension, Regenerative Medicine, Neuro- and Behavioral Pharmacology, Cancer Therapeutics Endocrinology, Diabetes, and Metabolism Lifespan Physiology.
Graduate Programs in Neuroscience
Program Research Interest: Addiction and Substance Abuse, Behavioral and Systems Neurobiology, Development and Plasticity, Molecular Neurobiology, Neurological Disease and Aging, Neuropharmacology, Sensory Neurobiology